UNSPSC 51191912: Idebenone

This classification denotes an antioxidant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HB6PN45W4J. European Medicines Agency schedules Idebenone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08114MIG. Idebenone generally arises in the molecular formula C19H30O5. The term IDEBENONE is an International Nomenclature of Cosmetic Ingredients designation. IDEBENONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule idebenone under HS 29146990 and SITC 51629. As of Q4 2014, IDEBENONE remains the US FDA Preferred Term for this commodity. Idebenone bears US NLM identifiers UMLS ID C0123163 and NCI Concept Code C74158. SMILES: OCCCCCCCCCCC1=C(C(=O)C(=C(OC)C1=O)OC)C.

UNSPSC 51191912 Idebenone is a Commodity code under which state and local governments procure pharmaceutical and chemical products for water treatment and healthcare facility operations. Recent solicitations show the code captures chemical supply for municipal water pollution control and generic pharmaceutical distribution through cooperative purchasing vehicles. The City of Meriden is soliciting sodium bisulfite (a water treatment chemical) for its Water Pollution Control Facility via IFB, with bids due July 29, 2026. Issuing bodies include municipalities operating water systems and state agencies administering multistate cooperative purchasing alliances. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities, with proposals due March 26, 2026. Vendors supplying under the code must maintain General Liability coverage of $1,000,000 to $5,000,000 per occurrence depending on the scope, secure manufacturer compliance certifications (cGMP and Drug Supply Chain Security Act), and agree to supply through specified authorized wholesalers.

Recent activity appears concentrated in the Midwest and Connecticut, with the MMCAP procurement spanning participating jurisdictions across Minnesota and Oregon. The Meriden solicitation shows ongoing municipal demand for water-treatment chemicals with firm pricing and performance bond requirements. The MMCAP RFP indicates substantial multistate and local-government demand for pharmaceutical products through cooperative channels, with pricing weighted at 75 percent of evaluation and administrative fees of 3 percent on all purchases. Vendors must demonstrate pricing flexibility across multiple net-price formats and maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen, Cardinal Health, or Morris & Dickson). The contract term extends two years for new respondents with optional extensions, and incumbents' amendments align through June 30, 2028.